Reference Library: Difference between revisions
Jump to navigation
Jump to search
Created page with "''As content accumulates, can think about appropriate organization.'' *Guidance Standards for CTs *Media:Guidance biomarker qualifi..." |
No edit summary |
||
| Line 1: | Line 1: | ||
''As content accumulates, can think about appropriate organization.'' | ''As content accumulates, we can think about appropriate organization.'' | ||
*[[Media:Guidance Standards for CTs.pdf|Guidance for Industry, Standards for Clinical Trial Imaging Endpoints]], Food and Drug Administration, August 2011, http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ | |||
*[[Media:Guidance biomarker qualification Aug 2011.pdf|Guidance biomarker qualification Aug 2011]] | *[[Media:Guidance biomarker qualification Aug 2011.pdf|Guidance biomarker qualification Aug 2011]] | ||
Revision as of 23:38, 3 May 2016
As content accumulates, we can think about appropriate organization.
- Guidance for Industry, Standards for Clinical Trial Imaging Endpoints, Food and Drug Administration, August 2011, http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/